Stay updated on Autologous TILs in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.

Latest updates to the Autologous TILs in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew content adds a concluding statement on events for evaluating study endpoints and expands details about lifileucel-based TIL therapies and their regimens across cohorts. It also updates enrollment numbers (225), location count (34), eligibility criteria, and recruitment status, while removing some contact information and older location listings.SummaryDifference6%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no other content changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Autologous TILs in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.